Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Xspray Pharma AB
Headquarters:
Solna, Sweden
Website:
http://xspraypharma.com/en/
Year Founded:
2003
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Per Andersson, PhD
Number Of Employees:
27
Enterprise Value:
$117,729,227
PE Ratio:
-4.15
Exchange/Ticker 1:
SSE:XSPRAY
Exchange/Ticker 2:
N/A
Latest Market Cap:
$113,217,416
BioCentury
|
Jul 3, 2024
Data Byte
Five PDUFA dates on deck for July
Decisions from FDA due on a nasal naloxone and Sprycel competitor, among others
Read More
BioCentury
|
May 20, 2024
Management Tracks
Chroma hires Jenny Marlowe as CDO
Plus: William Elder named CFO of CervoMed, and updates from Xspray and Senti
Read More
BioCentury
|
Feb 7, 2018
Distillery Therapeutics
Cancer
Read More
Items per page:
10
1 - 3 of 3
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help